21 related articles for article (PubMed ID: 12727120)
1. Gene transfer: Bax to the future for cancer therapy.
Lemoine NR; McNeish IA
Gut; 2004 Apr; 53(4):478-9. PubMed ID: 15016738
[No Abstract] [Full Text] [Related]
2. Icodextrin enhances survival in an intraperitoneal ovarian cancer murine model utilizing gene therapy.
Rocconi RP; Numnum MT; Zhu ZB; Lu B; Wang M; Rivera AA; Stoff-Khalili M; Alvarez RD; Curiel DT; Makhija S
Gynecol Oncol; 2006 Dec; 103(3):985-9. PubMed ID: 16857247
[TBL] [Abstract][Full Text] [Related]
3. Activity of the adenoviral E1A deletion mutant dl922-947 in ovarian cancer: comparison with E1A wild-type viruses, bioluminescence monitoring, and intraperitoneal delivery in icodextrin.
Lockley M; Fernandez M; Wang Y; Li NF; Conroy S; Lemoine N; McNeish I
Cancer Res; 2006 Jan; 66(2):989-98. PubMed ID: 16424034
[TBL] [Abstract][Full Text] [Related]
4. Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin.
Hosie K; Gilbert JA; Kerr D; Brown CB; Peers EM
Drug Deliv; 2001; 8(1):9-12. PubMed ID: 11280443
[TBL] [Abstract][Full Text] [Related]
5. Effects of intraperitoneal 4% icodextrin solution on the healing of bowel anastomoses and laparotomy incisions in rabbits.
Rodgers KE; Verco SJ; diZerega GS
Colorectal Dis; 2003 Jul; 5(4):324-30. PubMed ID: 12814410
[TBL] [Abstract][Full Text] [Related]
6. Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models.
Nielsen LL; Gurnani M; Syed J; Dell J; Hartman B; Cartwright M; Johnson RC
Hum Gene Ther; 1998 Mar; 9(5):681-94. PubMed ID: 9551616
[TBL] [Abstract][Full Text] [Related]
7. Icodextrin: a review of its use in peritoneal dialysis.
Frampton JE; Plosker GL
Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
[TBL] [Abstract][Full Text] [Related]
8. Practical considerations when prescribing icodextrin: a narrative review.
Silver SA; Harel Z; Perl J
Am J Nephrol; 2014; 39(6):515-27. PubMed ID: 24925229
[TBL] [Abstract][Full Text] [Related]
9. Development of a formulation that enhances gene expression and efficacy following intraperitoneal administration in rabbits and mice.
Engler H; Machemer TR; Schluep T; Wen SF; Quijano E; Wills KN; Harper AE; Maneval DC; Conroy SE
Mol Ther; 2003 Apr; 7(4):558-64. PubMed ID: 12727120
[TBL] [Abstract][Full Text] [Related]
10. [Icodextrin in peritoneal dialysis therapy].
Grzegorzewska AE; Antczak-Jedrzejczak D
Przegl Lek; 1999; 56(12):812-6. PubMed ID: 10789195
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
